Literature DB >> 20619307

Platelets as delivery systems for disease treatments.

Qizhen Shi1, Robert R Montgomery.   

Abstract

Platelets are small, anucleate, discoid shaped blood cells that play a fundamental role in hemostasis. Platelets contain a large number of biologically active molecules within cytoplasmic granules that are critical to normal platelet function. Because platelets circulate in blood through out the body, release biological molecules and mediators on demand and participate in hemostasis as well as many other pathophysiologic processes, targeting expression of proteins of interest to platelets and utilizing platelets as delivery systems for disease treatment would be a logical approach. This paper reviews the genetic therapy for inherited bleeding disorders utilizing platelets as delivery system, with a particular focus on platelet-derived FVIII for hemophilia A treatment.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619307      PMCID: PMC2991519          DOI: 10.1016/j.addr.2010.06.007

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  136 in total

Review 1.  Adeno-associated virus-mediated gene transfer of factor IX for treatment of hemophilia B by gene therapy.

Authors:  R W Herzog; K A High
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

Review 2.  AAV vectors for hemophilia B gene therapy.

Authors:  Hengjun Chao; Christopher E Walsh
Journal:  Mt Sinai J Med       Date:  2004-10

3.  Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy.

Authors:  Glenn P Niemeyer; Roland W Herzog; Jane Mount; Valder R Arruda; D Michael Tillson; John Hathcock; Frederik W van Ginkel; Katherine A High; Clinton D Lothrop
Journal:  Blood       Date:  2008-10-28       Impact factor: 22.113

Review 4.  The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production.

Authors:  Kenneth Kaushansky; Jonathan G Drachman
Journal:  Oncogene       Date:  2002-05-13       Impact factor: 9.867

5.  Proliferation, migration and platelet release by megakaryocytes in long-term bone marrow culture in collagen gel.

Authors:  M Mori; J Tsuchiyama; S Okada
Journal:  Cell Struct Funct       Date:  1993-12       Impact factor: 2.212

Review 6.  Inhibitor antibodies to factor VIII and factor IX: management.

Authors:  J M Lusher
Journal:  Semin Thromb Hemost       Date:  2000       Impact factor: 4.180

7.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.

Authors:  Rahul D Ballal; Marc F Botteman; Isaac Foley; Jennifer M Stephens; Caitlyn T Wilke; Ashish V Joshi
Journal:  Curr Med Res Opin       Date:  2008-01-29       Impact factor: 2.580

9.  Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes.

Authors:  S Deveaux; A Filipe; V Lemarchandel; J Ghysdael; P H Roméo; V Mignotte
Journal:  Blood       Date:  1996-06-01       Impact factor: 22.113

10.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.

Authors:  M I Bukrinsky; S Haggerty; M P Dempsey; N Sharova; A Adzhubel; L Spitz; P Lewis; D Goldfarb; M Emerman; M Stevenson
Journal:  Nature       Date:  1993-10-14       Impact factor: 69.504

View more
  20 in total

1.  Correction of murine Bernard-Soulier syndrome by lentivirus-mediated gene therapy.

Authors:  Sachiko Kanaji; Erin L Kuether; Scot A Fahs; Jocelyn A Schroeder; Jerry Ware; Robert R Montgomery; Qizhen Shi
Journal:  Mol Ther       Date:  2011-11-01       Impact factor: 11.454

Review 2.  Ex vivo gene transfer and correction for cell-based therapies.

Authors:  Luigi Naldini
Journal:  Nat Rev Genet       Date:  2011-03-29       Impact factor: 53.242

3.  Platelet-Membrane-Encapsulated Carvedilol with Improved Targeting Ability for Relieving Myocardial Ischemia-Reperfusion Injury.

Authors:  Tingting Zhou; Xuechao Yang; Tianyi Wang; Mingming Xu; Zhanghao Huang; Runze Yu; Yi Jiang; Youlang Zhou; Jiahai Shi
Journal:  Membranes (Basel)       Date:  2022-06-10

Review 4.  Platelets and their biomimetics for regenerative medicine and cancer therapies.

Authors:  Zhenhua Li; Shiqi Hu; Ke Cheng
Journal:  J Mater Chem B       Date:  2018-10-22       Impact factor: 6.331

5.  Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura.

Authors:  Mohammad S Abdelgawwad; Wenjing Cao; Liang Zheng; Nicole K Kocher; Lance A Williams; X Long Zheng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

6.  Treatment of Hemophilia A in Utero and Postnatally using Sheep as a Model for Cell and Gene Delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  J Genet Syndr Gene Ther       Date:  2012-05-25

7.  Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunity.

Authors:  Jocelyn A Schroeder; Juan Chen; Yingyu Chen; Yuanhua Cai; Hongyin Yu; Jeremy G Mattson; Paul E Monahan; Qizhen Shi
Journal:  Blood Adv       Date:  2021-03-09

Review 8.  Hemophilia A: an ideal disease to correct in utero.

Authors:  Christopher D Porada; Christopher Rodman; Glicerio Ignacio; Anthony Atala; Graça Almeida-Porada
Journal:  Front Pharmacol       Date:  2014-12-11       Impact factor: 5.810

9.  From blood to brain: blood cell-based biomimetic drug delivery systems.

Authors:  Yong-Jiang Li; Jun-Yong Wu; Jihua Liu; Xiaohan Qiu; Wenjie Xu; Tiantian Tang; Da-Xiong Xiang
Journal:  Drug Deliv       Date:  2021-06-18       Impact factor: 6.819

Review 10.  In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application.

Authors:  Graça Almeida-Porada; Anthony Atala; Christopher D Porada
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-30       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.